Clinical Trials
4 trialsNCT07416409 2026-02-18
Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
Deraya University
Completed
NCT05572645 2024-02-26
Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab
Fudan University
Completed
NCT02266173 2021-05-03
Observational Study of Pertuzumab Safety in Participants With Breast Cancer
Hoffmann-La Roche
Completed
NCT00833963 2019-05-16
MotHER
Genentech, Inc.
Completed